96227 ⎘
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Benzimidazole derivatives
#602Complexing agents and corresponding lanthanide complexes
#603Functionally-modified oligonucleotides and subunits thereof
#604AMINO-PYRIDINE-CONTAINING SPLEEN TYROSINE KINASE (SYK) INHIBITORS
#605Oligonucleotides for treating expanded repeat diseases
#606Triazole compounds that modualte HSP90 activity
#607Compounds and uses thereof for the modulation of hemoglobin
#608Acyclic nucleoside phosphonate diesters
#6092-(2-hydroxy-2-phenylethyl)-3-[(phenylmethyl)oxy]-4H-pyran-4-one of the formula P-3 and/or 2-[(E)-2-phenylethenyl]-3-[(phenylmethyl)oxy]-4H-Pyran-4-one of the formula P-4
#610Substituted (3S, 11aR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamides of formula (I) useful as HIV agents
#611Aminopyrimidines as SYK Inhibitors
#612Fused ring-containing oxazolidinones antibiotics
#613Chelated PSMA inhibitors
#614SUBSTITUTED 1H-PYRAZOL-1,2,4-OXADIAZOLE DERIVATIVES AS SPHINGOSINE RECEPTOR MODULATORS
#615SUBSTITUTED PYRAZOLES AS SPHINGOSINE RECEPTOR MODULATORS
#616Biaryl heterocycle substituted oxazolidinone antibacterial agents
#617Substituted pyrimidines
#618ERK inhibitors and uses thereof
#619Prodrugs of NH-acidic compounds
#620Compositions and methods for inhibition of the JAK pathway
#621No- and HS-releasing compounds
#622Luminescent probes for biological labeling and imaging, and process for preparing the same
#623Antibacterial antisense oligonucleotide and method
#624Methods for preparing oxazolidinones and compositions containing them
#625Compositions and methods for treatment of cancer
#626BCL-2/BCL-XL inhibitors and therapeutic methods using the same
#627NOVEL BENZIMIDAZOLE DERIVATIVES
#628Fused pyrimidine compounds and use thereof
#629Substituted indole derivatives
#630Phosphonoxy quinazoline derivatives and their pharmaceutical use
#631Method of using binuclear gold (I) compounds for cancer treatment
#632Phosphoric acid ester derivatives
#633Methods for preparing anti-viral nucleotide analogs
#634Phosphorus-substituted quinoxaline-type piperidine compounds and uses thereof
#635TRPV4 antagonists
#636Process for fosaprepitant
#637Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#638Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H
#639COMPOUNDS FOR USE IN THE TREATMENT OF FELINE RETROVIRAL INFECTIONS
#640Phosphorus derivatives as kinase inhibitors
#641OXAZOLIDINONE CONTAINING DIMER COMPOUNDS, COMPOSITIONS AND METHODS TO MAKE AND USE
#642Process for synthesizing oxidized lactam compounds
#643Bone targeted therapeutics and methods of making and using the same
#644Quinolone compound and pharmaceutical composition
#645O-(substituted benzyl) phosphoramidate compounds and therapeutic use
#646Triazacyclononane-based phosphinate ligand and its use for molecular imaging
#647Methods for Inhibiting Cell Proliferation in EGFR-Driven Cancers
#648Indole compounds as an inhibitor of cellular necrosis
#649Compositions and methods for inhibition of the JAK pathway
#650Prodrugs of 2,4-pyrimidinediamine compounds and their uses
#651Ring-substituted N-pyridinyl amides as kinase inhibitors
#652Phosphorus-containing group-substituted quinoline, its preparation process, medical composition containing the compounds and application
#653Tertiary amines, medicaments containing said amines, use thereof and processes for the preparation thereof
#654Compositions and methods for inhibition of the JAK pathway
#655Aminopyrimidine kinase inhibitors
#656PROCESS FOR THE PREPARATION OF PHOSPHORIC ACID MONO-(1--4-METHOXYMETHYL-PIPERIDIN-4-YL) ESTER
#657Oxazolidinone-quinolone hybrid antibiotics
#658Method for imaging zinc activation within a mitochondrion using a two-photon fluorescent probe, and method for manufacturing the two-photon fluorescent probe
#659Linked dibenzimidazole antivirals
#660Antisense antibacterial method and compound
#661Ruthenium complexes and their uses in processes for formation and/or hydrogenation of esters, amides and derivatives thereof
#662Oxazolidinone derivatives
#663Thiazole derivatives and their use as P2Y12 receptor antagonists
#664Adsorption of immunopotentiators to insoluble metal salts
#665Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#666THERAPEUTIC COMBINATION OF DAPTOMYCIN AND PROTEIN SYNTHESIS INHIBITOR ANTIBIOTIC, AND METHODS OF USE
#667Indole and indazole compounds as an inhibitor of cellular necrosis
#668Amino pyrimidine anticancer compounds
#669Phosphorus Derivatives as Kinase Inhibitors
#670Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
#671Morpholino nucleic acid derivatives
#672Alkoxy-substituted 2-aminopyridines as ALK inhibitors
#673In situ chemiluminescent substrates and assays
#674Small molecule inhibitors of the pleckstrin homology domain and methods for using same
#675MODULAR CONSTRUCTION OF LIPOPHOSPHOLIPIDS
#676Phenylquinazoline derivatives
#677Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms
#678Cannabinoid receptor modulators
#679Prostaglandin-bisphosphonate conjugate compounds, methods of making same, and uses thereof
#680Substituted pyrazines and their use in the treatment of disease
#681Substituted indole derivatives
#682Gonadotropin releasing hormone receptor antagonist, preparation method thereof and pharmaceutical composition comprising the same
#683Pyridine derivatives useful as kinase inhibitors
#684Electrochromic compound, electrochromic composition, and display device
#685Oligonucleotides comprising acyclic and abasic nucleosides and analogs
#686Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H
#687N-PHENYL-2-PYRIMIDINEAMINE DERIVATIVES
#688Highly efficient carbazole-based compound, and organic electroluminescence device comprising same
#689Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
#690Methods for preparing anti-viral nucleotide analogs
#691Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitors
#692Compounds useful as Raf kinase inhibitors
#693Photocleavable morpholino oligos with integral photolinkers for modulating the activity of any selected gene transcript by exposure to light
#694Phosphonate compounds
#695Minor groove binder phosphoramidites and methods of use
#696Aromatic compounds having sphingosine-1-phosphonate (S1P) receptor activity
#697Quinolone compound and pharmaceutical composition
#698Phospho-amino pincer-type ligands and catalytic metal complexes thereof
#699Morpholino-based antisense agent
#700Phosphonic acid compounds as inhibitors of serine proteases
#701Aminopyrimidines as SYK inhibitors
#702Phosphorous containing benzoxazine-based monomer, or polymer thereof
#703Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#704PROCESS FOR SYNTHESIZING PHOSPHONIC AND PHOSPHINIC ACID COMPOUNDS
#705Indole compounds as an inhibitor of cellular necrosis
#706Oligonucleotide derivative comprising an aromatic compound
#707Phosphonic acid compounds as inhibitors of serine proteases
#708Prodrugs of 2,4-pyrimidinediamine compounds and their uses
#709Squaric acid derivatives as inhibitors of the nicotinamide
#710Phosphorus containing compounds as protein kinase inhibitors
#711Cannabinoid receptor modulators
#712POLYDENTATE LIGAND METAL COMPLEX
#713PHOTOELECTRIC CONVERSION DEVICE AND SOLAR CELL USING THE SAME
#714Phosphorous derivatives as kinase inhibitors
#715Formulation of immunopotentiators
#716Fosfluconazole Derivatives, Synthesis, and Use in Long Acting Formulations
#717Oxazolidinone-quinolone hybrid antibiotics
#718PRODRUGS AND THE USE THEREOF
#719Chemical compound for organic electronic device and organic electronic device
#720Phosphonate fluorescent dyes and conjugates
#721Prodrugs of 2,4-pyrimidinediamine compounds and their uses
#722QUINOLINES AS INHIBITORS OF FARNESYL PYROPHOSPHATE SYNTHASE
#723Benzimidazole derivatives
#724Antimicrobial Cyclocarbonyl Heterocyclic Compounds For Treatment Of Bacterial Infections
#725Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
#726Phosphonate compounds
#727Splice-region antisense composition and method
#728Thiazole derivatives and their use as P2Y12 receptor antagonists
#729INHIBITORS OF HEPATITIS C VIRUS
#730Compositions and methods for inhibition of the JAK pathway
#731Chemical compounds
#732Compositions and methods for inhibition of the JAK pathway
#733Compositions and methods for inhibition of the JAK pathway
#734Compositions and methods for inhibition of the JAK pathway
#735Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives
#736Compositions and methods for inhibition of the JAK pathway
#737Compositions and methods for inhibition of the JAK pathway
#738Fosfluconazole Derivatives, Synthesis, and Use in Long Acting Formulations
#739Triheterocyclic compounds and compositions thereof
#740Prodrugs of 2,4-pyrimidinediamine compounds and their uses
#741Phosphonic acid compounds as inhibitors of serine proteases
#742Compound for organic electroluminescent device and organic electroluminescent device having the same
#743Activators of glucokinase
#744Organic electroluminescent device
#7451-(2H)-isoquinolone derivative
#746AROMATIC COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHONATE (S1P) RECEPTOR ACTIVITY
#747Process for synthesizing oxidized lactam compounds
#748Quinolone compound and pharmaceutical composition
#749Cyclic benzimidazole derivatives useful as anti-diabetic agents
#750Halofuginone analogs for inhibition of tRNA synthetases and uses thereof
#751NICOTINE-BASED COMPOUNDS USEFUL FOR ASYMMETRIC SYNTHESIS
#752Aminopyrimidines as SYK inhibitors
#753Electrochromic material and electrochromic device including the same
#754PREPARATION OF FOSAMPRENAVIR CALCIUM
#755Cyclic benzimidazole derivatives useful as anti-diabetic agents
#756Anti-viral compounds
#757Triazole compounds that modulate HSP90 activity
#758Electrochromic materials and electrochromic devices using the same
#759Methyl 3-(benzyloxy)-1-(2,2-dihydroxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate and processes for the preparation thereof
#760Photocleavable Linker Methods and Compositions
#761PRO-DRUGS OF (E)-7-(3-(2-AMINO-1-FLUOROETHYLIDENE)PIPERIDIN-1-YL)-1-CYCLOPROPYL-6-FLUORO-8-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
#762Small molecule inhibitors of the pleckstrin homology domain and methods for using same
#763Amino pyrimidine anticancer compounds
#764Fosaprepitant dimeglumine intermediate, neutral fosaprepitant, and amorphous fosaprepitant dimeglumine and processes for their preparations
#765Fluorinated Heteroaryls
#766Phosphonic acid compounds as inhibitors of serine proteases
#767Phosphonic acid compounds as inhibitors of serine proteases
#768Anti-Viral Compounds
#769Phosphonic acid compounds as inhibitors of serine proteases
#770Antiviral phosphinate compounds
#771Antiviral phosphinate compounds
#772Hepatitis C virus inhibitors
#773Hepatitis C virus inhibitors
#774Indolocarbazole derivative with aromatic phosphne oxide group for organic electroluminescent device and organic electroluminescent device containing same
#775Substituted 2-phenyl-pyridine derivatives
#776Heterocyclic compounds for the treatment of neurological and psychological disorders
#777PREPARATION OF MORPHOLINE DERIVATIVES
#778PRODRUGS OF CC-1065 ANALOGS
#779Prodrugs of NH-acidic compounds
#780PYRIDINE DERIVATIVE CONTAINING ((PHOSPHONOOXY)METHYL)PYRIDINIUM RING, AND ANTIFUNGAL AGENT CONTAINING THESE DERIVATIVE
#781Process for {3-[2(R)-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxo-4,5-dihydro-[1,2,4]-triazol-1-yl}phosphonic acid
#782CRYSTALLINE CINNAMIDE COMPOUNDS OR SALTS THEREOF
#783Anti-viral compounds
#784Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
#785Hepatitis C virus inhibitors
#786Oxazolidinone containing dimer compounds, compositions and methods to make and use
#787Diarylphosphine-containing compounds, processes of preparing same and uses thereof as tridentate ligands
#788Diarylphosphine- and dialkylphosphine-containing compounds, processes of preparing same and uses thereof as tridentate ligands
#789FLUORESCENT PHOSPHOLIPID ETHER COMPOUNDS, COMPOSITIONS, AND METHODS OF USE
#790Linked dibenzimidazole antivirals
#791Phosphonate fluorescent dyes and conjugates
#792Phosphonic acid derivates and their use as P2Yreceptor antagonists
#793HIV Protease Inhibiting Compounds
#794Antibacterial antisense oligonucleotide and method
#795Crystalline form of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
#796Linked diimidazole derivatives
#797Linked diimidazole antivirals
#798Compositions and methods for treatment of cancer
#799N-PHENYL-2-PYRIMIDINEAMINE DERIVATIVES
#800Linked dibenzimidazole derivatives
#801Indole compounds as an inhibitor of cellular necrosis
#802Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus
#803Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus
#804Indole and indazole compounds as an inhibitor of cellular necrosis
#805Compositions and methods for inhibition of the JAK pathway
#806Convertible nucleoside derivatives
#807Phosphonate compounds
#808Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
#809CYANINE DERIVATIVES, FLUORESCENT CONJUGATES CONTAINING SAME AND USE THEREOF
#810ANTISENSE ANTIBACTERIAL METHOD AND COMPOUND
#811Heterocyclic TRPV1 receptor ligands
#812Substituted pyrazines as inhibitors of kinase activity
#813Substituted piperidinophenyl oxazolidinones
#814Lyophilization formulation
#815Monophosphates as Mutual Prodrugs of Muscarinic Receptor Antagonists and Beta-Agonists for the Treatment of COPD And Chronic Bronchitis
#816Monophosphates as Mutual Prodrugs of Anti-Inflammatory Signal Transduction Modulators (AISTM's) and Beta-Agonists for the Treatment of Pulmonary Inflammation and Bronchoconstriction
#817Methods for preparing oxazolidinones and compositions containing them
#818Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#819Phosphonoxy quinazoline derivatives and their pharmaceutical use
#820Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway
#821Electrochromic materials and electrochromic devices using the same
#822Photocleavable linker methods and compositions
#823PYRAZOLYLAMINO SUBSTITUTED QUINAZOLES FOR THE TREATMENT OF CANCER
#824Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
#825Chemical compounds
#826ANTIVIRAL PROTEASE INHIBITORS
#827Substituted N-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity
#828Nitrons Carrying a Positive Charge and Usable in Trapping Free Radicals, Especially the Superoxide Radical
#829Prodrugs of CC-1065 analogs
#830ARYLMETHYLIDENE HETEROCYCLES AS NOVEL ANALGESICS
#831Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
#832Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
#833Bone targeted therapeutics and methods of making and using the same
#834ANTIVIRAL PHOSPHINATE COMPOUNDS
#835Process for preparation of water-soluble azole prodrugs
#836Oxazolidinone derivatives
#837Phospho-indoles as HIV inhibitors
#838Phosphonic acid compounds as inhibitors of serine proteases
#839Novel phosphonic acid compounds as inhibitors of serine proteases
#840Novel phosphonic acid compounds as inhibitors of serine proteases
#841Phosphonic acid compounds as inhibitors of serine proteases
#842Process for synthesizing phosphonic and phosphinic acid compounds
#843Novel phosphonic acid compounds as inhibitors of serine proteases
#844Prodrugs of 2,4-pyrimidinediamine compounds and their uses
#845Phosphonic acid compounds as inhibitors of serine proteases
#846Novel phosphonic acid compounds as inhibitors of serine proteases
#847Heteroaromatic Compounds As Inhibitors Of Stearoyl-Coenzyme A Delta-9 Desaturase
#848Phosphonic acid compounds as inhibitors of serine proteases
#849Novel phosphonic acid compounds as inhibitors of serine proteases
#850Antiviral protease inhibitors
#851Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
#852Phosphorous containing benzoxazine-based monomer, polymer thereof, electrode for fuel cell including the same, electrolyte membrane for fuel cell including the same, and fuel cell employing the same
#853Prodrug of cinnamide compound
#854NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#855Compounds useful as Raf kinase inhibitors
#856Novel inhibitors of chymase
#857MULTINUCLEAR COMPLEX AND POLYMER THEREOF
#858Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
#859Methods for treating cancer
#860Triheterocyclic compounds and compositions thereof
#861Antiviral Compounds
#862Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
#863Phosphonated Fluoroquinolones, Antibacterial Analogs Thereof, and Methods for the Prevention and Treatment of Bone and Joint Infections
#864Novel 2,4-Dianilinopyrimidine Derivatives, the Preparation Thereof, Their Use as Medicaments, Pharmaceutical Compositions and, in Particular, as IKK Inhibitors
#865Inositol-phosphate derivatives and method of detecting inositol-1-phosphate
#866Prodrugs of CC-1065 analogs
#867Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS
#868ORGANIC ELECTROLUMINESCENT DEVICE
#869PHOSPHONYLATED FLUORESCENT DYES AND CONJUGATES
#870Compounds For the Inhibition of Undesired Cell Proliferation and Use Thereof
#871Antibacterial antisense oligonucleotide and method
#872ANTI-INFECTIVE PHOSPHONATE ANALOGS
#873FATTY AMINE DRUG CONJUGATES
#874Benzoxazepine compounds, their production and use
#875Pyrimidyl Phosphonate Antiviral Compounds and Methods of Use
#876Nitrobenzindoles and their use in cancer therapy
#877Phosphonate compounds
#8782-Imidazolone and 2-Imidazolidinone Heterocyclic Inhibitors of Tyrosine Phosphatases
#879Antiviral phosphinate compounds
#880Co-crystal
#881Oxazolidinone-quinolone hybrid antibiotics
#882Cyclic compounds
#883COMPOSITIONS AND METHODS FOR POLYMER COMPOSITES
#884Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
#885Preparation of N-protected-3-pyrrolidine-lactam substituted phosphonium salts
#886Nitrons carrying a positive charge and usable in trapping free radicals, especially the superoxide radical
#887Inhibitors of β-lactamase
#888Process and intermediate
#889Process for {3-[2()-[(1)-1-[3,5-bis(trifluoromethyl) phenyl]ethoxy]-3()-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxo-4,5-dihydro-[1,2,4]-triazol-1-yl}phosphonic acid
#890Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
#891Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives
#892Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
#893Substituted Aminothiazole Derivatives With Anti-HCV Activity
#894Antibacterial agents
#895Method and compositions for identifying anti-hiv therapeutic compounds
#896Phosphonate fluorescent dyes and conjugates
#897Phosphonate compounds
#898Oxazolidinone derivatives
#899Pyridyl Alkene and Pyridyl Alkine-Acid Amides as Cytostatics and Immunosuppressives
#900Prodrugs of CC-1065 analogs